AB FIA can announce a recent installation of two fully automated inhaler test systems for manufacturing QC at a major global pharma company. It is a DPI test system which builds on FIA’s successful ADS concept, including automated dose, waste and semi-automated ACI/MLI/NGI testing. The project is a continuation of previous installations at two of the customer’s R&D sites where the systems are also configured for fully automated abbreviated impactor measurements (AIM).
